COVID-19 ” Operation Warp Speed” Vaccine Finalists Selected
June 3, 2020
By Neozene

This article originally appeared in FiercePharma and was written by Eric Sagonowsky  The Trump administration has selected its COVID-19 vaccine finalists for Operation Warp Speed, which aims to deliver safe and effective coronavirus vaccines to Americans by the end of the year, The New York Times reports. The finalists—from AstraZeneca, Merck, Pfizer, Johnson & Johnson and Moderna—have a clear Big Pharma slant, with biotechs like Inovio and Novavax being left off the list. Moderna is the smallest company among the group, but the biotech is pressing ahead into mid- and late-stage

Read More

Harvard Study Suggests COVID Protection Can Come From Previous Infection or DNA Vaccine
May 21, 2020
By Neozene

The following is from FierceBiotech and was written by Arlene Weintraub In all the excitement over the potential for a quick vaccine to prevent COVID-19, one burning question has emerged: Are the antibodies that form in response to the virus adequate for fending off future infections? Scientists led by Harvard University have published two studies that they believe begin to answer that question. In one study, nine macaques that were infected with SARS-CoV-2 and then recovered were protected against the disease when they were exposed to it again 35 days later.

Read More

Neozene Obtains PPE Gear for Clients, Helping Them Get Back to Work Safely
May 6, 2020
By Neozene

In response to the ongoing battle against COVID-19 (“Coronavirus”), Neozene has been working tirelessly to find a way to provide its partners with personal protective equipment (PPE). We are proud to announce that our efforts have been successful. Neozene, Inc. is pleased to offer our close partners access to Personal Protective Equipment (PPE), procured through the Neozene Board of Physicians. For many years, Neozene has run clinical trials and FDA compliance efforts for pharmaceutical and medical device companies across the nation. With the tagline “Safety in Medicine,” Neozene consistently goes above

Read More